Oligosol Copper Gold Silver 60ml

$18.99
  • Estimated Delivery:Nov 29 - Dec 03

  • Free Shipping: for all orders over $40

STANDARD ITEM delivery in 7-14 days Click here for Shipping Policy
Oligosol Copper Gold Silver 60ml

Oligosol Copper Gold Silver 60ml

$18.99
Product Information

Oligosol Cuivre Or Argent - 

Indications: Supports wellness during recovery and helps reduce fatigue – For Adults

Who It’s For: Adults, Adolescents (ages 15 and up)
Pregnancy: Not recommended
Breastfeeding: Not recommended
Form: Oral solution, 60 ml bottle (30 doses)

Description
Oligosol Copper Gold Silver is a gentle trace element therapy designed to support the body’s natural recovery processes and boost energy levels. Ideal for times of low energy or when you’re bouncing back, this solution provides trace minerals to promote overall wellness.

Ingredients
Each dose of Oligosol Copper Gold Silver contains essential trace elements in purified water:

  • Copper Gluconate: 22.5 mg (equivalent to 63 µg of copper)
  • Colloidal Gold: 0.07 mg (1.4 µg of gold)
  • Silver Gluconate: 3.0 mg (21.36 µg of silver)

Directions for Use
For adults and adolescents 15 years and older:

  • Take 1 to 2 doses daily, measuring 2 ml (first graduation) to 4 ml (second graduation) per dose.
  • Administer sublingually: hold the solution under the tongue for 1-2 minutes before swallowing.
  • For best results, take 15 minutes before or after meals.

Storage Instructions
Store Oligosol Copper Gold Silver in a cool, dry place, away from light, at a temperature below 25°C. Avoid use after the expiration date printed on the packaging.

Packaging: 60 ml bottle

Please read the following full disclosure before purchasing or using this product.

Product Summary

ANSM – Updated on: 01/08/2023

1. Product Name
CUIVRE-OR-ARGENT OLIGOSOL, oral solution in bottle

2. Qualitative and Quantitative Composition

  • Copper gluconate: 22.50 mg (equivalent to 3.150 mg of copper)
  • Colloidal gold: 0.070 mg
  • Silver gluconate: 3.000 mg (equivalent to 1.068 mg of silver)

Per 100 ml of oral solution.

The measuring cap has two graduations for 2 ml (1 dose) and 4 ml (2 doses).

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form
Oral solution in a bottle.

4. Clinical Data

4.1. Therapeutic Indications
Used as a terrain modulator, particularly during the recovery phase from infectious illnesses and for states of fatigue.

4.2. Dosage and Administration

Dosage
For adults only.

The measuring cap graduations indicate 2 ml (1 dose) or 4 ml (2 doses).

Doses should be taken:

  • Preferably in the morning on an empty stomach,
  • Or 15 minutes before a meal if needed.

Hold the contents under the tongue for 1 to 2 minutes before swallowing.

Administration Method
Oral. Sublingual administration is recommended.

4.3. Contraindications
Hypersensitivity to active ingredients or any excipient listed in section 6.1.

4.4. Special Warnings and Precautions
Very rare cases of argyria have been reported with prolonged use and/or overdose (see sections 4.8 and 4.9).

4.5. Interactions with Other Medicines
Available data does not indicate clinically significant interactions.

4.6. Fertility, Pregnancy, and Breastfeeding
Due to a lack of experimental and clinical data, this medication should be avoided during pregnancy and breastfeeding as a precaution.

4.7. Effects on Driving and Using Machines
CUIVRE-OR-ARGENT OLIGOSOL oral solution has no effect on the ability to drive or operate machinery.

4.8. Adverse Reactions
This medication is generally well-tolerated; the main reported side effects include:

  • Gastrointestinal disorders: abdominal pain, nausea, vomiting, occasional diarrhea or constipation.
  • Immune system disorders: rare cases of hypersensitivity reactions, such as erythema or urticaria, requiring discontinuation of the medication (frequency unknown).
  • Skin and subcutaneous disorders: very rare cases of argyria (frequency unknown).
  • Nervous system disorders: dysgeusia (metallic taste, frequency unknown).

Reporting of Suspected Adverse Reactions
Reporting suspected adverse reactions post-authorization is important for continuous monitoring of the benefit-risk balance. Healthcare professionals report all suspected adverse reactions via the national reporting system: ANSM and Regional Pharmacovigilance Centers - Website: www.signalement-sante.gouv.fr

4.9. Overdose
Prolonged or excessive use may cause an accumulation of silver salts in the skin (argyria).

Symptoms include slight gray or bluish-gray coloration, especially on the hands (notably under the nails) or sun-exposed areas, requiring treatment discontinuation.

5. Pharmacological Properties

5.1. Pharmacodynamic Properties
Pharmacotherapeutic class: OLIGOTHERAPY (V: miscellaneous)

Trace mineral elements.

6. Pharmaceutical Data

6.1. List of Excipients
Purified water.

6.2. Incompatibilities
None applicable.

6.3. Shelf Life
2 years.

6.4. Special Storage Precautions
Store below 25°C, away from light.

6.5. Nature and Contents of the Container
60 ml yellow high-density polyethylene (HDPE) bottle (30 doses per bottle), sealed with a tamper-evident cap (natural HDPE) and graduated polypropylene measuring cap at 2 ml (1 dose) and 4 ml (2 doses).

6.6. Disposal Precautions
No specific requirements.

7. Marketing Authorization Holder
LABCATAL
1198 AVENUE DU DOCTEUR MAURICE DONAT
ZAC DU FONT DE L’ORME
06250 MOUGINS

8. Marketing Authorization Number(s)

  • 34009 307 507 9 7: 60 ml bottle (polyethylene) with measuring cap. Box of 1 bottle.

9. Date of First Authorization/Renewal
[To be completed by the holder]

10. Date of Text Revision
[To be completed by the holder]

Prescription and Supply Conditions
Non-prescription medication.